1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Molecular Diagnostics Cancer Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Pharmacogenomic Diagnosis
1.2.3 Liquid Biopsy
1.2.4 Other
1.3 Market by Application
1.3.1 Global Molecular Diagnostics Cancer Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Respiratory Cancer
1.3.3 Cancer of Digestive System
1.3.4 Cancer of Urinary System
1.3.5 Cancer of Circulatory System
1.3.6 Motor System Cancer
1.3.7 Reproductive System Cancer
1.3.8 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Molecular Diagnostics Cancer Market Perspective (2017-2028)
2.2 Molecular Diagnostics Cancer Growth Trends by Region
2.2.1 Molecular Diagnostics Cancer Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Molecular Diagnostics Cancer Historic Market Size by Region (2017-2022)
2.2.3 Molecular Diagnostics Cancer Forecasted Market Size by Region (2023-2028)
2.3 Molecular Diagnostics Cancer Market Dynamics
2.3.1 Molecular Diagnostics Cancer Industry Trends
2.3.2 Molecular Diagnostics Cancer Market Drivers
2.3.3 Molecular Diagnostics Cancer Market Challenges
2.3.4 Molecular Diagnostics Cancer Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Molecular Diagnostics Cancer Players by Revenue
3.1.1 Global Top Molecular Diagnostics Cancer Players by Revenue (2017-2022)
3.1.2 Global Molecular Diagnostics Cancer Revenue Market Share by Players (2017-2022)
3.2 Global Molecular Diagnostics Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Molecular Diagnostics Cancer Revenue
3.4 Global Molecular Diagnostics Cancer Market Concentration Ratio
3.4.1 Global Molecular Diagnostics Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Molecular Diagnostics Cancer Revenue in 2021
3.5 Molecular Diagnostics Cancer Key Players Head office and Area Served
3.6 Key Players Molecular Diagnostics Cancer Product Solution and Service
3.7 Date of Enter into Molecular Diagnostics Cancer Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Molecular Diagnostics Cancer Breakdown Data by Type
4.1 Global Molecular Diagnostics Cancer Historic Market Size by Type (2017-2022)
4.2 Global Molecular Diagnostics Cancer Forecasted Market Size by Type (2023-2028)
5 Molecular Diagnostics Cancer Breakdown Data by Application
5.1 Global Molecular Diagnostics Cancer Historic Market Size by Application (2017-2022)
5.2 Global Molecular Diagnostics Cancer Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Molecular Diagnostics Cancer Market Size (2017-2028)
6.2 North America Molecular Diagnostics Cancer Market Size by Type
6.2.1 North America Molecular Diagnostics Cancer Market Size by Type (2017-2022)
6.2.2 North America Molecular Diagnostics Cancer Market Size by Type (2023-2028)
6.2.3 North America Molecular Diagnostics Cancer Market Share by Type (2017-2028)
6.3 North America Molecular Diagnostics Cancer Market Size by Application
6.3.1 North America Molecular Diagnostics Cancer Market Size by Application (2017-2022)
6.3.2 North America Molecular Diagnostics Cancer Market Size by Application (2023-2028)
6.3.3 North America Molecular Diagnostics Cancer Market Share by Application (2017-2028)
6.4 North America Molecular Diagnostics Cancer Market Size by Country
6.4.1 North America Molecular Diagnostics Cancer Market Size by Country (2017-2022)
6.4.2 North America Molecular Diagnostics Cancer Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Molecular Diagnostics Cancer Market Size (2017-2028)
7.2 Europe Molecular Diagnostics Cancer Market Size by Type
7.2.1 Europe Molecular Diagnostics Cancer Market Size by Type (2017-2022)
7.2.2 Europe Molecular Diagnostics Cancer Market Size by Type (2023-2028)
7.2.3 Europe Molecular Diagnostics Cancer Market Share by Type (2017-2028)
7.3 Europe Molecular Diagnostics Cancer Market Size by Application
7.3.1 Europe Molecular Diagnostics Cancer Market Size by Application (2017-2022)
7.3.2 Europe Molecular Diagnostics Cancer Market Size by Application (2023-2028)
7.3.3 Europe Molecular Diagnostics Cancer Market Share by Application (2017-2028)
7.4 Europe Molecular Diagnostics Cancer Market Size by Country
7.4.1 Europe Molecular Diagnostics Cancer Market Size by Country (2017-2022)
7.4.2 Europe Molecular Diagnostics Cancer Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Molecular Diagnostics Cancer Market Size (2017-2028)
8.2 Asia-Pacific Molecular Diagnostics Cancer Market Size by Type
8.2.1 Asia-Pacific Molecular Diagnostics Cancer Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Molecular Diagnostics Cancer Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Molecular Diagnostics Cancer Market Share by Type (2017-2028)
8.3 Asia-Pacific Molecular Diagnostics Cancer Market Size by Application
8.3.1 Asia-Pacific Molecular Diagnostics Cancer Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Molecular Diagnostics Cancer Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Molecular Diagnostics Cancer Market Share by Application (2017-2028)
8.4 Asia-Pacific Molecular Diagnostics Cancer Market Size by Region
8.4.1 Asia-Pacific Molecular Diagnostics Cancer Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Molecular Diagnostics Cancer Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Molecular Diagnostics Cancer Market Size (2017-2028)
9.2 Latin America Molecular Diagnostics Cancer Market Size by Type
9.2.1 Latin America Molecular Diagnostics Cancer Market Size by Type (2017-2022)
9.2.2 Latin America Molecular Diagnostics Cancer Market Size by Type (2023-2028)
9.2.3 Latin America Molecular Diagnostics Cancer Market Share by Type (2017-2028)
9.3 Latin America Molecular Diagnostics Cancer Market Size by Application
9.3.1 Latin America Molecular Diagnostics Cancer Market Size by Application (2017-2022)
9.3.2 Latin America Molecular Diagnostics Cancer Market Size by Application (2023-2028)
9.3.3 Latin America Molecular Diagnostics Cancer Market Share by Application (2017-2028)
9.4 Latin America Molecular Diagnostics Cancer Market Size by Country
9.4.1 Latin America Molecular Diagnostics Cancer Market Size by Country (2017-2022)
9.4.2 Latin America Molecular Diagnostics Cancer Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Molecular Diagnostics Cancer Market Size (2017-2028)
10.2 Middle East & Africa Molecular Diagnostics Cancer Market Size by Type
10.2.1 Middle East & Africa Molecular Diagnostics Cancer Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Molecular Diagnostics Cancer Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Molecular Diagnostics Cancer Market Share by Type (2017-2028)
10.3 Middle East & Africa Molecular Diagnostics Cancer Market Size by Application
10.3.1 Middle East & Africa Molecular Diagnostics Cancer Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Molecular Diagnostics Cancer Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Molecular Diagnostics Cancer Market Share by Application (2017-2028)
10.4 Middle East & Africa Molecular Diagnostics Cancer Market Size by Country
10.4.1 Middle East & Africa Molecular Diagnostics Cancer Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Molecular Diagnostics Cancer Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Molecular Diagnostics Cancer Introduction
11.1.4 Roche Revenue in Molecular Diagnostics Cancer Business (2017-2022)
11.1.5 Roche Recent Developments
11.2 Danaher
11.2.1 Danaher Company Details
11.2.2 Danaher Business Overview
11.2.3 Danaher Molecular Diagnostics Cancer Introduction
11.2.4 Danaher Revenue in Molecular Diagnostics Cancer Business (2017-2022)
11.2.5 Danaher Recent Developments
11.3 Siemens
11.3.1 Siemens Company Details
11.3.2 Siemens Business Overview
11.3.3 Siemens Molecular Diagnostics Cancer Introduction
11.3.4 Siemens Revenue in Molecular Diagnostics Cancer Business (2017-2022)
11.3.5 Siemens Recent Developments
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Details
11.4.2 Abbott Laboratories Business Overview
11.4.3 Abbott Laboratories Molecular Diagnostics Cancer Introduction
11.4.4 Abbott Laboratories Revenue in Molecular Diagnostics Cancer Business (2017-2022)
11.4.5 Abbott Laboratories Recent Developments
11.5 ICON Plc
11.5.1 ICON Plc Company Details
11.5.2 ICON Plc Business Overview
11.5.3 ICON Plc Molecular Diagnostics Cancer Introduction
11.5.4 ICON Plc Revenue in Molecular Diagnostics Cancer Business (2017-2022)
11.5.5 ICON Plc Recent Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Molecular Diagnostics Cancer Introduction
11.6.4 AstraZeneca Revenue in Molecular Diagnostics Cancer Business (2017-2022)
11.6.5 AstraZeneca Recent Developments
11.7 MDxHealth
11.7.1 MDxHealth Company Details
11.7.2 MDxHealth Business Overview
11.7.3 MDxHealth Molecular Diagnostics Cancer Introduction
11.7.4 MDxHealth Revenue in Molecular Diagnostics Cancer Business (2017-2022)
11.7.5 MDxHealth Recent Developments
11.8 Invitae
11.8.1 Invitae Company Details
11.8.2 Invitae Business Overview
11.8.3 Invitae Molecular Diagnostics Cancer Introduction
11.8.4 Invitae Revenue in Molecular Diagnostics Cancer Business (2017-2022)
11.8.5 Invitae Recent Developments
11.9 PlexBio
11.9.1 PlexBio Company Details
11.9.2 PlexBio Business Overview
11.9.3 PlexBio Molecular Diagnostics Cancer Introduction
11.9.4 PlexBio Revenue in Molecular Diagnostics Cancer Business (2017-2022)
11.9.5 PlexBio Recent Developments
11.10 Thermo Fisher Scientific
11.10.1 Thermo Fisher Scientific Company Details
11.10.2 Thermo Fisher Scientific Business Overview
11.10.3 Thermo Fisher Scientific Molecular Diagnostics Cancer Introduction
11.10.4 Thermo Fisher Scientific Revenue in Molecular Diagnostics Cancer Business (2017-2022)
11.10.5 Thermo Fisher Scientific Recent Developments
11.11 Guardant Health
11.11.1 Guardant Health Company Details
11.11.2 Guardant Health Business Overview
11.11.3 Guardant Health Molecular Diagnostics Cancer Introduction
11.11.4 Guardant Health Revenue in Molecular Diagnostics Cancer Business (2017-2022)
11.11.5 Guardant Health Recent Developments
11.12 Biocartis
11.12.1 Biocartis Company Details
11.12.2 Biocartis Business Overview
11.12.3 Biocartis Molecular Diagnostics Cancer Introduction
11.12.4 Biocartis Revenue in Molecular Diagnostics Cancer Business (2017-2022)
11.12.5 Biocartis Recent Developments
11.13 Bio-Techne
11.13.1 Bio-Techne Company Details
11.13.2 Bio-Techne Business Overview
11.13.3 Bio-Techne Molecular Diagnostics Cancer Introduction
11.13.4 Bio-Techne Revenue in Molecular Diagnostics Cancer Business (2017-2022)
11.13.5 Bio-Techne Recent Developments
11.14 Merck
11.14.1 Merck Company Details
11.14.2 Merck Business Overview
11.14.3 Merck Molecular Diagnostics Cancer Introduction
11.14.4 Merck Revenue in Molecular Diagnostics Cancer Business (2017-2022)
11.14.5 Merck Recent Developments
11.15 Foundation Medicine
11.15.1 Foundation Medicine Company Details
11.15.2 Foundation Medicine Business Overview
11.15.3 Foundation Medicine Molecular Diagnostics Cancer Introduction
11.15.4 Foundation Medicine Revenue in Molecular Diagnostics Cancer Business (2017-2022)
11.15.5 Foundation Medicine Recent Developments
11.16 10X Genomics
11.16.1 10X Genomics Company Details
11.16.2 10X Genomics Business Overview
11.16.3 10X Genomics Molecular Diagnostics Cancer Introduction
11.16.4 10X Genomics Revenue in Molecular Diagnostics Cancer Business (2017-2022)
11.16.5 10X Genomics Recent Developments
11.17 Biodesix
11.17.1 Biodesix Company Details
11.17.2 Biodesix Business Overview
11.17.3 Biodesix Molecular Diagnostics Cancer Introduction
11.17.4 Biodesix Revenue in Molecular Diagnostics Cancer Business (2017-2022)
11.17.5 Biodesix Recent Developments
11.18 CytoTrack
11.18.1 CytoTrack Company Details
11.18.2 CytoTrack Business Overview
11.18.3 CytoTrack Molecular Diagnostics Cancer Introduction
11.18.4 CytoTrack Revenue in Molecular Diagnostics Cancer Business (2017-2022)
11.18.5 CytoTrack Recent Developments
11.19 GenomOncology
11.19.1 GenomOncology Company Details
11.19.2 GenomOncology Business Overview
11.19.3 GenomOncology Molecular Diagnostics Cancer Introduction
11.19.4 GenomOncology Revenue in Molecular Diagnostics Cancer Business (2017-2022)
11.19.5 GenomOncology Recent Developments
11.20 Luminex
11.20.1 Luminex Company Details
11.20.2 Luminex Business Overview
11.20.3 Luminex Molecular Diagnostics Cancer Introduction
11.20.4 Luminex Revenue in Molecular Diagnostics Cancer Business (2017-2022)
11.20.5 Luminex Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Molecular Diagnostics Cancer Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Pharmacogenomic Diagnosis
Table 3. Key Players of Liquid Biopsy
Table 4. Key Players of Other
Table 5. Global Molecular Diagnostics Cancer Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Molecular Diagnostics Cancer Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Molecular Diagnostics Cancer Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Molecular Diagnostics Cancer Market Share by Region (2017-2022)
Table 9. Global Molecular Diagnostics Cancer Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Molecular Diagnostics Cancer Market Share by Region (2023-2028)
Table 11. Molecular Diagnostics Cancer Market Trends
Table 12. Molecular Diagnostics Cancer Market Drivers
Table 13. Molecular Diagnostics Cancer Market Challenges
Table 14. Molecular Diagnostics Cancer Market Restraints
Table 15. Global Molecular Diagnostics Cancer Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Molecular Diagnostics Cancer Revenue Share by Players (2017-2022)
Table 17. Global Top Molecular Diagnostics Cancer by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostics Cancer as of 2021)
Table 18. Ranking of Global Top Molecular Diagnostics Cancer Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Molecular Diagnostics Cancer Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Molecular Diagnostics Cancer Product Solution and Service
Table 22. Date of Enter into Molecular Diagnostics Cancer Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Molecular Diagnostics Cancer Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Molecular Diagnostics Cancer Revenue Market Share by Type (2017-2022)
Table 26. Global Molecular Diagnostics Cancer Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Molecular Diagnostics Cancer Revenue Market Share by Type (2023-2028)
Table 28. Global Molecular Diagnostics Cancer Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Molecular Diagnostics Cancer Revenue Share by Application (2017-2022)
Table 30. Global Molecular Diagnostics Cancer Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Molecular Diagnostics Cancer Revenue Share by Application (2023-2028)
Table 32. North America Molecular Diagnostics Cancer Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America Molecular Diagnostics Cancer Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America Molecular Diagnostics Cancer Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America Molecular Diagnostics Cancer Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America Molecular Diagnostics Cancer Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Molecular Diagnostics Cancer Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Molecular Diagnostics Cancer Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe Molecular Diagnostics Cancer Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe Molecular Diagnostics Cancer Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe Molecular Diagnostics Cancer Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe Molecular Diagnostics Cancer Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe Molecular Diagnostics Cancer Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Molecular Diagnostics Cancer Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Molecular Diagnostics Cancer Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Molecular Diagnostics Cancer Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Molecular Diagnostics Cancer Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Molecular Diagnostics Cancer Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Molecular Diagnostics Cancer Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America Molecular Diagnostics Cancer Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America Molecular Diagnostics Cancer Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America Molecular Diagnostics Cancer Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America Molecular Diagnostics Cancer Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America Molecular Diagnostics Cancer Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America Molecular Diagnostics Cancer Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Molecular Diagnostics Cancer Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Molecular Diagnostics Cancer Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Molecular Diagnostics Cancer Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Molecular Diagnostics Cancer Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Molecular Diagnostics Cancer Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Molecular Diagnostics Cancer Market Size by Country (2023-2028) & (US$ Million)
Table 62. Roche Company Details
Table 63. Roche Business Overview
Table 64. Roche Molecular Diagnostics Cancer Product
Table 65. Roche Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million)
Table 66. Roche Recent Developments
Table 67. Danaher Company Details
Table 68. Danaher Business Overview
Table 69. Danaher Molecular Diagnostics Cancer Product
Table 70. Danaher Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million)
Table 71. Danaher Recent Developments
Table 72. Siemens Company Details
Table 73. Siemens Business Overview
Table 74. Siemens Molecular Diagnostics Cancer Product
Table 75. Siemens Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million)
Table 76. Siemens Recent Developments
Table 77. Abbott Laboratories Company Details
Table 78. Abbott Laboratories Business Overview
Table 79. Abbott Laboratories Molecular Diagnostics Cancer Product
Table 80. Abbott Laboratories Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million)
Table 81. Abbott Laboratories Recent Developments
Table 82. ICON Plc Company Details
Table 83. ICON Plc Business Overview
Table 84. ICON Plc Molecular Diagnostics Cancer Product
Table 85. ICON Plc Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million)
Table 86. ICON Plc Recent Developments
Table 87. AstraZeneca Company Details
Table 88. AstraZeneca Business Overview
Table 89. AstraZeneca Molecular Diagnostics Cancer Product
Table 90. AstraZeneca Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million)
Table 91. AstraZeneca Recent Developments
Table 92. MDxHealth Company Details
Table 93. MDxHealth Business Overview
Table 94. MDxHealth Molecular Diagnostics Cancer Product
Table 95. MDxHealth Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million)
Table 96. MDxHealth Recent Developments
Table 97. Invitae Company Details
Table 98. Invitae Business Overview
Table 99. Invitae Molecular Diagnostics Cancer Product
Table 100. Invitae Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million)
Table 101. Invitae Recent Developments
Table 102. PlexBio Company Details
Table 103. PlexBio Business Overview
Table 104. PlexBio Molecular Diagnostics Cancer Product
Table 105. PlexBio Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million)
Table 106. PlexBio Recent Developments
Table 107. Thermo Fisher Scientific Company Details
Table 108. Thermo Fisher Scientific Business Overview
Table 109. Thermo Fisher Scientific Molecular Diagnostics Cancer Product
Table 110. Thermo Fisher Scientific Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million)
Table 111. Thermo Fisher Scientific Recent Developments
Table 112. Guardant Health Company Details
Table 113. Guardant Health Business Overview
Table 114. Guardant Health Molecular Diagnostics Cancer Product
Table 115. Guardant Health Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million)
Table 116. Guardant Health Recent Developments
Table 117. Biocartis Company Details
Table 118. Biocartis Business Overview
Table 119. Biocartis Molecular Diagnostics Cancer Product
Table 120. Biocartis Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million)
Table 121. Biocartis Recent Developments
Table 122. Bio-Techne Company Details
Table 123. Bio-Techne Business Overview
Table 124. Bio-Techne Molecular Diagnostics Cancer Product
Table 125. Bio-Techne Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million)
Table 126. Bio-Techne Recent Developments
Table 127. Merck Company Details
Table 128. Merck Business Overview
Table 129. Merck Molecular Diagnostics Cancer Product
Table 130. Merck Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million)
Table 131. Merck Recent Developments
Table 132. Foundation Medicine Company Details
Table 133. Foundation Medicine Business Overview
Table 134. Foundation Medicine Molecular Diagnostics Cancer Product
Table 135. Foundation Medicine Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million)
Table 136. Foundation Medicine Recent Developments
Table 137. 10X Genomics Company Details
Table 138. 10X Genomics Business Overview
Table 139. 10X Genomics Molecular Diagnostics Cancer Product
Table 140. 10X Genomics Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million)
Table 141. 10X Genomics Recent Developments
Table 142. Biodesix Company Details
Table 143. Biodesix Business Overview
Table 144. Biodesix Molecular Diagnostics Cancer Product
Table 145. Biodesix Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million)
Table 146. Biodesix Recent Developments
Table 147. CytoTrack Company Details
Table 148. CytoTrack Business Overview
Table 149. CytoTrack Molecular Diagnostics Cancer Product
Table 150. CytoTrack Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million)
Table 151. CytoTrack Recent Developments
Table 152. GenomOncology Company Details
Table 153. GenomOncology Business Overview
Table 154. GenomOncology Molecular Diagnostics Cancer Product
Table 155. GenomOncology Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million)
Table 156. GenomOncology Recent Developments
Table 157. Luminex Company Details
Table 158. Luminex Business Overview
Table 159. Luminex Molecular Diagnostics Cancer Product
Table 160. Luminex Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million)
Table 161. Luminex Recent Developments
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Molecular Diagnostics Cancer Market Share by Type: 2021 VS 2028
Figure 2. Pharmacogenomic Diagnosis Features
Figure 3. Liquid Biopsy Features
Figure 4. Other Features
Figure 5. Global Molecular Diagnostics Cancer Market Share by Application: 2021 VS 2028
Figure 6. Respiratory Cancer Case Studies
Figure 7. Cancer of Digestive System Case Studies
Figure 8. Cancer of Urinary System Case Studies
Figure 9. Cancer of Circulatory System Case Studies
Figure 10. Motor System Cancer Case Studies
Figure 11. Reproductive System Cancer Case Studies
Figure 12. Other Case Studies
Figure 13. Molecular Diagnostics Cancer Report Years Considered
Figure 14. Global Molecular Diagnostics Cancer Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 15. Global Molecular Diagnostics Cancer Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Molecular Diagnostics Cancer Market Share by Region: 2021 VS 2028
Figure 17. Global Molecular Diagnostics Cancer Market Share by Players in 2021
Figure 18. Global Top Molecular Diagnostics Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostics Cancer as of 2021)
Figure 19. The Top 10 and 5 Players Market Share by Molecular Diagnostics Cancer Revenue in 2021
Figure 20. North America Molecular Diagnostics Cancer Market Size YoY (2017-2028) & (US$ Million)
Figure 21. North America Molecular Diagnostics Cancer Market Size Market Share by Type (2017-2028)
Figure 22. North America Molecular Diagnostics Cancer Market Size Market Share by Application (2017-2028)
Figure 23. North America Molecular Diagnostics Cancer Market Size Share by Country (2017-2028)
Figure 24. United States Molecular Diagnostics Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Canada Molecular Diagnostics Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Europe Molecular Diagnostics Cancer Market Size YoY (2017-2028) & (US$ Million)
Figure 27. Europe Molecular Diagnostics Cancer Market Size Market Share by Type (2017-2028)
Figure 28. Europe Molecular Diagnostics Cancer Market Size Market Share by Application (2017-2028)
Figure 29. Europe Molecular Diagnostics Cancer Market Size Share by Country (2017-2028)
Figure 30. Germany Molecular Diagnostics Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. France Molecular Diagnostics Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. U.K. Molecular Diagnostics Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Italy Molecular Diagnostics Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Russia Molecular Diagnostics Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Nordic Countries Molecular Diagnostics Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Asia-Pacific Molecular Diagnostics Cancer Market Size YoY (2017-2028) & (US$ Million)
Figure 37. Asia Pacific Molecular Diagnostics Cancer Market Size Market Share by Type (2017-2028)
Figure 38. Asia Pacific Molecular Diagnostics Cancer Market Size Market Share by Application (2017-2028)
Figure 39. Asia Pacific Molecular Diagnostics Cancer Market Size Share by Region (2017-2028)
Figure 40. China Molecular Diagnostics Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Japan Molecular Diagnostics Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. South Korea Molecular Diagnostics Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Southeast Asia Molecular Diagnostics Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. India Molecular Diagnostics Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Australia Molecular Diagnostics Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 46. Latin America Molecular Diagnostics Cancer Market Size YoY (2017-2028) & (US$ Million)
Figure 47. Latin America Molecular Diagnostics Cancer Market Size Market Share by Type (2017-2028)
Figure 48. Latin America Molecular Diagnostics Cancer Market Size Market Share by Application (2017-2028)
Figure 49. Latin America Molecular Diagnostics Cancer Market Size Share by Country (2017-2028)
Figure 50. Mexico Molecular Diagnostics Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Brazil Molecular Diagnostics Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Middle East & Africa Molecular Diagnostics Cancer Market Size YoY (2017-2028) & (US$ Million)
Figure 53. Middle East and Africa Molecular Diagnostics Cancer Market Size Market Share by Type (2017-2028)
Figure 54. Middle East and Africa Molecular Diagnostics Cancer Market Size Market Share by Application (2017-2028)
Figure 55. Middle East and Africa Molecular Diagnostics Cancer Market Size Share by Country (2017-2028)
Figure 56. Turkey Molecular Diagnostics Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. Saudi Arabia Molecular Diagnostics Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 58. UAE Molecular Diagnostics Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 59. Roche Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022)
Figure 60. Danaher Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022)
Figure 61. Siemens Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022)
Figure 62. Abbott Laboratories Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022)
Figure 63. ICON Plc Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022)
Figure 64. AstraZeneca Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022)
Figure 65. MDxHealth Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022)
Figure 66. Invitae Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022)
Figure 67. PlexBio Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022)
Figure 68. Thermo Fisher Scientific Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022)
Figure 69. Guardant Health Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022)
Figure 70. Biocartis Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022)
Figure 71. Bio-Techne Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022)
Figure 72. Merck Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022)
Figure 73. Foundation Medicine Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022)
Figure 74. 10X Genomics Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022)
Figure 75. Biodesix Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022)
Figure 76. CytoTrack Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022)
Figure 77. GenomOncology Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022)
Figure 78. Luminex Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022)
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed
